Deinove (ALDEI)

Business description

Deinove is a biotech company that discovers, develops and manufactures compounds of industrial interest stemming from rare bacteria and intended for the health, nutrition and beauty markets.

Quest for commercial revenue

Outlook | Alternative Energy | 08/05/2015

Commercial agreements with blue-chip industrials partners offer the prospect of entry into key markets for Deinove. To capitalise on this opportunity Deinove must demonstrate that its technology can operate successfully on an industrial scale and using industrial substrates in its chosen markets. Confirmation of its ability to scale up its technology could act as a significant boost to its share price.

Edison's research is freely available. We will never ask for your credit card details and you do not need to register. By downloading this research you are agreeing to our terms and conditions, which you can read in full here.

Stock data

Market cap.€19.6m
Last close€1.802
High / Low (52 weeks)€2.2 / €1.6
Stock market listingEG
Forecast net debt (€m)5.1
Forecast gearing ratio (%)2716
TeamIndustrials
SectorAlternative Energy

Price performance

%1m3m12m
Actual6.6(1)(20.3)
Relative *3.5(3.5)(30.4)

* % Relative to local index

Company news